Trial Details
COMPLETEDBasic Information
| Clinical ID | c2873 |
|---|---|
| Identifier | NCT02852694 |
| Trial Title | Reduce Risk for Crohn's Disease Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Methotrexate|DRUG: Adalimumab|DRUG: Azathioprine / 6 Mercaptopurine |
Participant Information
| Sponsor | PIBD-Net |
|---|---|
| City | Paris |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2017-02-28 |
|---|---|
| Primary Completion Date | 2021-06-14 |
| Completion Date | 2021-06-14 |